References
- Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081–90. doi:https://doi.org/10.1016/j.ophtha.2014.05.013.
- Shields MB. Normal-tension glaucoma: is it different from primary open-angle glaucoma? Curr Opin Ophthalmol. 2008;19:85–88. doi:https://doi.org/10.1097/ICU.0b013e3282f3919b.
- Caprioli JM, Coleman ALMP. Intraocular pressure fluctuation. Ophthalmology. 2008;115:1123–29. doi:https://doi.org/10.1016/j.ophtha.2007.10.031.
- Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268–79. doi:https://doi.org/10.1001/archopht.120.10.1268.
- Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998;126:498–505. doi:https://doi.org/10.1016/S0002-9394(98)00272-4.
- Musch DC, Gillespie BW, Lichter PR, Niziol LM, Janz NK. Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology. 2009;116:200–07. doi:https://doi.org/10.1016/j.ophtha.2008.08.051.
- Fan N, Wang P, Tang L, Liu X. Ocular blood flow and normal tension glaucoma. Biomed Res Int. 2015;2015:1–7.
- Chung HS, Harris A, Kagemann L, Martin B. Peripapillary retinal blood flow in normal tension glaucoma. Br J Ophthalmol. 1999;83:466–69. doi:https://doi.org/10.1136/bjo.83.4.466.
- Kitazawa Y, Shirai H, Go FJ. The effect of Ca2(+) -antagonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 1989;227:408–12. doi:https://doi.org/10.1007/BF02172889.
- Netland PA, Chaturvedi N, Dreyer EB. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol. 1993;115:608–13. doi:https://doi.org/10.1016/S0002-9394(14)71458-8.
- Piltz JR, Bose S, Lanchoney D. The effect of nimodipine, a centrally active calcium antagonist, on visual function and mascular blood flow in patients with normal-tension glaucoma and control subjects. J Glaucoma. 1998;7:336–42. doi:https://doi.org/10.1097/00061198-199810000-00008.
- Luksch A. Effect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma. Br J Ophthalmol. 2005;89:21–25. doi:https://doi.org/10.1136/bjo.2003.037671.
- Sygnecka K, Heine C, Scherf N, Fasold M, Binder H, Scheller C, Franke H. Nimodipine enhances neurite outgrowth in dopaminergic brain slice co-cultures. Int J Dev Neurosci. 2015;40:1–11. doi:https://doi.org/10.1016/j.ijdevneu.2014.10.005.
- Tomassoni D, Lanari A, Silvestrelli G, Traini E, Amenta F. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies. Clin Exp Hypertens. 2008;30:744–66. doi:https://doi.org/10.1080/10641960802580232.
- Araie M, Mayama C. Use of calcium channel blockers for glaucoma. Prog Retin Eye Res. 2011;30:54–71.
- Boehm AG, Breidenbach KA, Pillunat LE, Bernd AS, Mueller MF, Koeller AU. Visual function and perfusion of the optic nerve head after application of centrally acting calcium-channel blockers. Graefe’s Arch Clin Exp Ophthalmol. 2003;241:34–38. doi:https://doi.org/10.1007/s00417-002-0592-6.
- Michalk F, Michelson G, Harazny J, Werner U, Daniel WG, Werner D. Single-dose nimodipine normalizes impaired retinal circulation in normal tension glaucoma. J Glaucoma. 2004;13:158–62. doi:https://doi.org/10.1097/00061198-200404000-00013.
- Jia Y, Wei E, Wang X, Zhang X, Morrison JC, Parikh M, Lombardi LH, Gattey DM, Armour RL, Edmunds B, et al. Optical coherence tomography angiography of optic disc perfusion in glaucoma. Ophthalmology. 2014;121:1322–32. doi:https://doi.org/10.1016/j.ophtha.2014.01.021.
- Spaide RF, Klancnik JJ, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015;133:45–50. doi:https://doi.org/10.1001/jamaophthalmol.2014.3616.
- Wang X, Jiang C, Ko T, Kong X, Yu X, Min W, Shi G, Sun X. Correlation between optic disc perfusion and glaucomatous severity in patients with open-angle glaucoma: an optical coherence tomography angiography study. Graefe’s Arch Clin Exp Ophthalmol. 2015;253:1557–64. doi:https://doi.org/10.1007/s00417-015-3095-y.
- Kaeser P, Orgul S, Zawinka C, Reinhard G, Flammer J. Influence of change in body position on choroidal blood flow in normal subjects. Br J Ophthalmol. 2005;89:1302–05. doi:https://doi.org/10.1136/bjo.2005.067884.
- Jia Y, Tan O, Tokayer J, Potsaid B, Wang Y, Liu JJ, Kraus MF, Subhash H, Fujimoto JG, Hornegger J, et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express. 2012;20:4710–25. doi:https://doi.org/10.1364/OE.20.004710.
- Ch’Ng TW, Gillmann K, Hoskens K, Rao HL, Mermoud A, Mansouri K. Effect of surgical intraocular pressure lowering on retinal structures - nerve fibre layer, foveal avascular zone, peripapillary and macular vessel density: 1 year results. Eye (Lond). 2020;34:562–71. doi:https://doi.org/10.1038/s41433-019-0560-6.
- Liu L, Jia Y, Takusagawa HL, Pechauer AD, Edmunds B, Lombardi L, Davis E, Morrison JC, Huang D. Optical coherence tomography angiography of the peripapillary retina in glaucoma. JAMA Ophthalmol. 2015;133:1045–52. doi:https://doi.org/10.1001/jamaophthalmol.2015.2225.
- Akagi T, Iida Y, Nakanishi H, Terada N, Morooka S, Yamada H, Hasegawa T, Yokota S, Yoshikawa M, Yoshimura N. Microvascular density in glaucomatous eyes with hemifield visual field defects: an optical coherence tomography angiography study. Am J Ophthalmol. 2016;168:237–49. doi:https://doi.org/10.1016/j.ajo.2016.06.009.
- Yarmohammadi A, Zangwill LM, Diniz-Filho A, Suh MH, Yousefi S, Saunders LJ, Belghith A, Manalastas PI, Medeiros FA, Weinreb RN. Relationship between optical coherence tomography angiography vessel density and severity of visual field loss in glaucoma. Ophthalmology. 2016;123:2498–508. doi:https://doi.org/10.1016/j.ophtha.2016.08.041.
- In JH, Lee SY, Cho SH, Hong YJ. Peripapillary vessel density reversal after trabeculectomy in glaucoma. J Ophthalmol. 2018;2018:8909714. doi:https://doi.org/10.1155/2018/8909714.
- Shin JW, Sung KR, Uhm KB, Jo J, Moon Y, Song MK, Song JY. Peripapillary microvascular improvement and lamina cribrosa depth reduction after trabeculectomy in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2017;58:5993–99. doi:https://doi.org/10.1167/iovs.17-22787.
- Kim JA, Kim TW, Lee EJ, Girard M, Mari JM. Microvascular changes in peripapillary and optic nerve head tissues after trabeculectomy in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2018;59:4614–21. doi:https://doi.org/10.1167/iovs.18-25038.
- Mohamed AA, Gotoh O, Graham DI, Osborne KA, McCulloch J, Mendelow AD, Teasdale GM, Harper AM. Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion. Ann Neurol. 1985;18:705–11. doi:https://doi.org/10.1002/ana.410180613.
- Haefliger IO, Dettmann E, Liu R, Meyer P, Prünte C, Messerli J, Flammer J. Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma. Surv Ophthalmol. 1999;43(Suppl 1):S51–S58. doi:https://doi.org/10.1016/S0039-6257(99)00026-0.
- Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res. 2001;20:319–49.
- Mozaffarieh M, Grieshaber MC, Flammer J. Oxygen and blood flow: players in the pathogenesis of glaucoma. Mol Vis. 2008;14:224–33.
- Fard MA, Ghahvechian H, Sahrayan A, Subramanian PS. Early macular vessel density loss in acute ischemic optic neuropathy compared to papilledema: implications for pathogenesis. Transl Vis Sci Technol. 2018;7:10. doi:https://doi.org/10.1167/tvst.7.5.10.
- Honda H, Anraku A, Ishida K, Enomoto N, Tomita G. Relationship between macular vessel density and focal electroretinograms in early normal tension glaucoma. Curr Eye Res. 2019;44:753–59. doi:https://doi.org/10.1080/02713683.2019.1593464.